Differential impact of <i>IDH1</i>/<i>2</i> mutational subclasses on outcome in adult AML: results from a large multicenter studyJan Moritz Middeke, Christian Thiede, Jan‐Niklas Eckardt et al.|Blood Advances|2021Cited by 44
Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemiaLeo Ruhnke, Christoph Röllig, Marius Bill et al.|Blood Advances|2024Cited by 17